Hidenori Toyoda

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi et al. · Journal of Clinical Oncology · 2014 · 2.8K citations · Full text

Medicine, Oncology, Clinical Epidemiology +16

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

Yoshiki Murakami, Tomoharu Yasuda, Kenichi Saigo et al. · Oncogene · 2005 · 1.1K citations

Medicine, Molecular Biology, Oncology +17

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

Anthony W.H. Chan, Jian‐Hong Zhong, Sarah Berhane et al. · Journal of Hepatology · 2018 · 551 citations · Full text

Medicine, Oncology, Surgery +16

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara et al. · The Lancet Infectious Diseases · 2015 · 362 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Rong Fan, George Papatheodoridis, Jian Sun et al. · Journal of Hepatology · 2020 · 349 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16